Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Bronchiectasis Economics: Spend Money to Save Money.

Goeminne PC, Vanfleteren LEGW.

Respiration. 2018;96(5):399-402. doi: 10.1159/000490550. Epub 2018 Jul 24. No abstract available.

PMID:
30041195
2.

The impact of acute air pollution fluctuations on bronchiectasis pulmonary exacerbation: a case-crossover analysis.

Goeminne PC, Cox B, Finch S, Loebinger MR, Bedi P, Hill AT, Fardon TC, de Hoogh K, Nawrot TS, Chalmers JD.

Eur Respir J. 2018 Jul 27;52(1). pii: 1702557. doi: 10.1183/13993003.02557-2017. Print 2018 Jul.

PMID:
29903857
3.

Oral versus inhaled antibiotics for bronchiectasis.

Spencer S, Felix LM, Milan SJ, Normansell R, Goeminne PC, Chalmers JD, Donovan T.

Cochrane Database Syst Rev. 2018 Mar 27;3:CD012579. doi: 10.1002/14651858.CD012579.pub2. Review.

PMID:
29587336
4.

The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis.

Araújo D, Shteinberg M, Aliberti S, Goeminne PC, Hill AT, Fardon TC, Obradovic D, Stone G, Trautmann M, Davis A, Dimakou K, Polverino E, De Soyza A, McDonnell MJ, Chalmers JD.

Eur Respir J. 2018 Jan 31;51(2). pii: 1701953. doi: 10.1183/13993003.01953-2017. Print 2018 Feb.

PMID:
29386336
5.

Characterization of the "Frequent Exacerbator Phenotype" in Bronchiectasis.

Chalmers JD, Aliberti S, Filonenko A, Shteinberg M, Goeminne PC, Hill AT, Fardon TC, Obradovic D, Gerlinger C, Sotgiu G, Operschall E, Rutherford RM, Dimakou K, Polverino E, De Soyza A, McDonnell MJ.

Am J Respir Crit Care Med. 2018 Jun 1;197(11):1410-1420. doi: 10.1164/rccm.201711-2202OC.

PMID:
29357265
6.

Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis Network.

Chalmers JD, Ringshausen FC, Harris B, Elborn JS, Posthumus A, Haworth CS, Pilkington N, Polverino E, Ruddy T, Aliberti S, Goeminne PC, Winstanley C, De Soyza A.

Eur Respir J. 2018 Jan 11;51(1). pii: 1701937. doi: 10.1183/13993003.01937-2017. Print 2018 Jan. No abstract available.

PMID:
29326319
7.

Anti-MDA5 positive dermatomyositis complicated with rapidly progressive interstitial lung disease - a case report.

De Backer E, Gremonprez F, Brusselle G, Depuydt P, Van Dorpe J, Van Haverbeke C, Goeminne PC, Derom E.

Acta Clin Belg. 2017 Dec 29:1-5. doi: 10.1080/17843286.2017.1420521. [Epub ahead of print]

PMID:
29287518
8.

The BRICS (Bronchiectasis Radiologically Indexed CT Score): A Multicenter Study Score for Use in Idiopathic and Postinfective Bronchiectasis.

Bedi P, Chalmers JD, Goeminne PC, Mai C, Saravanamuthu P, Velu PP, Cartlidge MK, Loebinger MR, Jacob J, Kamal F, Schembri N, Aliberti S, Hill U, Harrison M, Johnson C, Screaton N, Haworth C, Polverino E, Rosales E, Torres A, Benegas MN, Rossi AG, Patel D, Hill AT.

Chest. 2018 May;153(5):1177-1186. doi: 10.1016/j.chest.2017.11.033. Epub 2017 Dec 13.

PMID:
29247616
9.

Standardised classification of the aetiology of bronchiectasis using an objective algorithm.

Araújo D, Shteinberg M, Aliberti S, Goeminne PC, Hill AT, Fardon T, Obradovic D, Dimakou K, Polverino E, De Soyza A, McDonnell MJ, Chalmers JD.

Eur Respir J. 2017 Dec 14;50(6). pii: 1701289. doi: 10.1183/13993003.01289-2017. Print 2017 Dec. No abstract available.

PMID:
29242262
10.

The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC): experiences from a successful ERS Clinical Research Collaboration.

Chalmers JD, Crichton M, Goeminne PC, Loebinger MR, Haworth C, Almagro M, Vendrell M, De Soyza A, Dhar R, Morgan L, Blasi F, Aliberti S, Boyd J, Polverino E.

Breathe (Sheff). 2017 Sep;13(3):180-192. doi: 10.1183/20734735.005117. Review.

11.

European Respiratory Society guidelines for the management of adult bronchiectasis.

Polverino E, Goeminne PC, McDonnell MJ, Aliberti S, Marshall SE, Loebinger MR, Murris M, Cantón R, Torres A, Dimakou K, De Soyza A, Hill AT, Haworth CS, Vendrell M, Ringshausen FC, Subotic D, Wilson R, Vilaró J, Stallberg B, Welte T, Rohde G, Blasi F, Elborn S, Almagro M, Timothy A, Ruddy T, Tonia T, Rigau D, Chalmers JD.

Eur Respir J. 2017 Sep 9;50(3). pii: 1700629. doi: 10.1183/13993003.00629-2017. Print 2017 Sep.

PMID:
28889110
12.

Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research.

Hill AT, Haworth CS, Aliberti S, Barker A, Blasi F, Boersma W, Chalmers JD, De Soyza A, Dimakou K, Elborn JS, Feldman C, Flume P, Goeminne PC, Loebinger MR, Menendez R, Morgan L, Murris M, Polverino E, Quittner A, Ringshausen FC, Tino G, Torres A, Vendrell M, Welte T, Wilson R, Wong C, O'Donnell A, Aksamit T; EMBARC/BRR definitions working group.

Eur Respir J. 2017 Jun 8;49(6). pii: 1700051. doi: 10.1183/13993003.00051-2017. Print 2017 Jun.

PMID:
28596426
13.

Cluster analysis of sputum cytokine-high profiles reveals diversity in T(h)2-high asthma patients.

Seys SF, Scheers H, Van den Brande P, Marijsse G, Dilissen E, Van Den Bergh A, Goeminne PC, Hellings PW, Ceuppens JL, Dupont LJ, Bullens DM.

Respir Res. 2017 Feb 23;18(1):39. doi: 10.1186/s12931-017-0524-y.

14.

Bronchiectasis Rheumatoid Overlap Syndrome Is an Independent Risk Factor for Mortality in Patients With Bronchiectasis: A Multicenter Cohort Study.

De Soyza A, McDonnell MJ, Goeminne PC, Aliberti S, Lonni S, Davison J, Dupont LJ, Fardon TC, Rutherford RM, Hill AT, Chalmers JD.

Chest. 2017 Jun;151(6):1247-1254. doi: 10.1016/j.chest.2016.12.024. Epub 2017 Jan 16.

15.

End-stage cystic fibrosis lung disease is characterised by a diverse inflammatory pattern: an immunohistochemical analysis.

Lammertyn EJ, Vandermeulen E, Bellon H, Everaerts S, Verleden SE, Van Den Eynde K, Bracke KR, Brusselle GG, Goeminne PC, Verbeken EK, Vanaudenaerde BM, Dupont LJ.

Respir Res. 2017 Jan 10;18(1):10. doi: 10.1186/s12931-016-0489-2.

16.

Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study.

McDonnell MJ, Aliberti S, Goeminne PC, Restrepo MI, Finch S, Pesci A, Dupont LJ, Fardon TC, Wilson R, Loebinger MR, Skrbic D, Obradovic D, De Soyza A, Ward C, Laffey JG, Rutherford RM, Chalmers JD.

Lancet Respir Med. 2016 Dec;4(12):969-979. doi: 10.1016/S2213-2600(16)30320-4. Epub 2016 Nov 16.

17.

Continuous alternating inhaled antibiotic therapy in CF: A single center retrospective analysis.

Van de Kerkhove C, Goeminne PC, Kicinski M, Nawrot TS, Lorent N, Van Bleyenbergh P, De Boeck K, Dupont LJ.

J Cyst Fibros. 2016 Nov;15(6):802-808. doi: 10.1016/j.jcf.2016.09.002. Epub 2016 Oct 5.

18.

Characterization of bronchiectasis in the elderly.

Bellelli G, Chalmers JD, Sotgiu G, Dore S, McDonnell MJ, Goeminne PC, Dimakou K, Skrbic D, Lombi A, Pane F, Obradovic D, Fardon TC, Rutherford RM, Pesci A, Aliberti S.

Respir Med. 2016 Oct;119:13-19. doi: 10.1016/j.rmed.2016.08.008. Epub 2016 Aug 17.

19.

Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts.

McDonnell MJ, Aliberti S, Goeminne PC, Dimakou K, Zucchetti SC, Davidson J, Ward C, Laffey JG, Finch S, Pesci A, Dupont LJ, Fardon TC, Skrbic D, Obradovic D, Cowman S, Loebinger MR, Rutherford RM, De Soyza A, Chalmers JD.

Thorax. 2016 Dec;71(12):1110-1118. doi: 10.1136/thoraxjnl-2016-208481. Epub 2016 Aug 11.

20.

Clinical phenotypes in adult patients with bronchiectasis.

Aliberti S, Lonni S, Dore S, McDonnell MJ, Goeminne PC, Dimakou K, Fardon TC, Rutherford R, Pesci A, Restrepo MI, Sotgiu G, Chalmers JD.

Eur Respir J. 2016 Apr;47(4):1113-22. doi: 10.1183/13993003.01899-2015. Epub 2016 Feb 4.

21.

Bronchiectasis: how to be an orphan with many parents?

Goeminne PC, De Soyza A.

Eur Respir J. 2016 Jan;47(1):10-3. doi: 10.1183/13993003.01567-2015. No abstract available.

22.

Etiology of Non-Cystic Fibrosis Bronchiectasis in Adults and Its Correlation to Disease Severity.

Lonni S, Chalmers JD, Goeminne PC, McDonnell MJ, Dimakou K, De Soyza A, Polverino E, Van de Kerkhove C, Rutherford R, Davison J, Rosales E, Pesci A, Restrepo MI, Torres A, Aliberti S.

Ann Am Thorac Soc. 2015 Dec;12(12):1764-70. doi: 10.1513/AnnalsATS.201507-472OC.

23.

Proximity to blue spaces and risk of infection with Pseudomonas aeruginosa in cystic fibrosis: A case-control analysis.

Goeminne PC, Nawrot TS, De Boeck K, Nemery B, Dupont LJ.

J Cyst Fibros. 2015 Nov;14(6):741-7. doi: 10.1016/j.jcf.2015.04.004. Epub 2015 May 2.

24.

Impact of traffic related air pollution indicators on non-cystic fibrosis bronchiectasis mortality: a cohort analysis.

Goeminne PC, Bijnens E, Nemery B, Nawrot TS, Dupont LJ.

Respir Res. 2014 Sep 3;15:108. doi: 10.1186/s12931-014-0108-z.

25.

Genetic variation in immunoglobulin G receptor affects survival after lung transplantation.

Ruttens D, Verleden SE, Goeminne PC, Vandermeulen E, Wauters E, Cox B, Vos R, Van Raemdonck DE, Lambrechts D, Vanaudenaerde BM, Verleden GM.

Am J Transplant. 2014 Jul;14(7):1672-7. doi: 10.1111/ajt.12745. Epub 2014 May 6.

26.

Mortality in non-cystic fibrosis bronchiectasis: a prospective cohort analysis.

Goeminne PC, Nawrot TS, Ruttens D, Seys S, Dupont LJ.

Respir Med. 2014 Feb;108(2):287-96. doi: 10.1016/j.rmed.2013.12.015. Epub 2014 Jan 8.

27.

The Sputum Colour Chart as a predictor of lung inflammation, proteolysis and damage in non-cystic fibrosis bronchiectasis: a case-control analysis.

Goeminne PC, Vandooren J, Moelants EA, Decraene A, Rabaey E, Pauwels A, Seys S, Opdenakker G, Proost P, Dupont LJ.

Respirology. 2014 Feb;19(2):203-210. doi: 10.1111/resp.12219. Epub 2013 Nov 29.

28.

Smoking resumption after lung transplantation: standardised screening and importance for long-term outcome.

Ruttens D, Verleden SE, Goeminne PC, Poels K, Vandermeulen E, Godderis L, Van Raemdonck DE, Vanaudenaerde BM, Vanoirbeek J, Vos R, Verleden GM.

Eur Respir J. 2014 Jan;43(1):300-3. doi: 10.1183/09031936.00141113. Epub 2013 Aug 29. No abstract available.

29.

Papain-induced asthma: a man with dyspnea from dawn till dust.

Goeminne PC, Adams E, Deschepper K, Valcke Y, Nemery B.

Acta Clin Belg. 2013 Mar-Apr;68(2):132-4.

PMID:
23967724
30.

Effect of macrolide on lung function and computed tomography (CT) score in non-cystic fibrosis bronchiectasis.

Goeminne PC, Soens J, Scheers H, De Wever W, Dupont L.

Acta Clin Belg. 2012 Sep-Oct;67(5):338-46.

PMID:
23189541
31.

A cohort description and analysis of the effect of gabapentin on idiopathic cough.

Van de Kerkhove C, Goeminne PC, Van Bleyenbergh P, Dupont LJ.

Cough. 2012 Nov 1;8(1):9. doi: 10.1186/1745-9974-8-9.

32.

Impact of air pollution on cystic fibrosis pulmonary exacerbations: a case-crossover analysis.

Goeminne PC, Kiciński M, Vermeulen F, Fierens F, De Boeck K, Nemery B, Nawrot TS, Dupont LJ.

Chest. 2013 Apr;143(4):946-954. doi: 10.1378/chest.12-1005.

PMID:
23081770
33.

Detection of Pseudomonas aeruginosa in sputum headspace through volatile organic compound analysis.

Goeminne PC, Vandendriessche T, Van Eldere J, Nicolai BM, Hertog ML, Dupont LJ.

Respir Res. 2012 Oct 2;13:87. doi: 10.1186/1465-9921-13-87.

34.

Higher food intake and appreciation with a new food delivery system in a Belgian hospital. Meals on Wheels, a bedside meal approach: a prospective cohort trial.

Goeminne PC, De Wit EH, Burtin C, Valcke Y.

Appetite. 2012 Aug;59(1):108-16. doi: 10.1016/j.appet.2012.04.008. Epub 2012 Apr 19.

PMID:
22521517
35.

Risk factors for morbidity and death in non-cystic fibrosis bronchiectasis: a retrospective cross-sectional analysis of CT diagnosed bronchiectatic patients.

Goeminne PC, Scheers H, Decraene A, Seys S, Dupont LJ.

Respir Res. 2012 Mar 16;13:21. doi: 10.1186/1465-9921-13-21.

36.

Frog sign.

Goeminne PC, Voet J.

Neth Heart J. 2013 Sep;21(9):421-2. doi: 10.1007/s12471-011-0215-0. No abstract available.

37.

Safety of immunomodulatory therapy in patients with bronchiectasis associated with rheumatic disease and IBD: a retrospective and cohort analysis.

Goeminne PC, Verschueren P, Scheers H, Dupont LJ.

Clin Rheumatol. 2012 Feb;31(2):367-73. doi: 10.1007/s10067-011-1849-4. Epub 2011 Sep 22.

PMID:
21938452
38.

The sinusitis-infertility syndrome: Young's saint, old devil.

Goeminne PC, Dupont LJ.

Eur Respir J. 2010 Mar;35(3):698. doi: 10.1183/09031936.00163809. No abstract available.

Supplemental Content

Loading ...
Support Center